NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market Wednesday that its second quarter revenues rose 6 percent compared to Q2 of 2015.

For the period ended Jan. 31, 2015, the company reported total revenues of $24.6 million, up from $23.1 million in Q2 of 2015. Clinical lab services revenues rose 19 percent to $17.5 million from $14.7 million a year ago. The company credited increased demand for molecular diagnostics testing at higher reimbursement rates for the increase.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.